Field Trip's new psychedelic molecule, FT-104, is showing similar efficacy to psychedelics like psilocybin -- but with shorter duration.
Articles
Psychedelic Stocks Offer Great Buying Opportunity In Weak Markets
Markets are tumbling. Where do you want to be positioned AFTER the selloff is over? Psychedelic stocks.
Wuhan General Group Updates on University of Pretoria Research Collaboration for Psilocybin Magic Mushroom Clinical Trials
M2Bio Sciences (Wuhan General Group) has finalized an agreement with the University of Pretoria (South Africa) to conduct a psilocybin-based clinical trial.
New recreational cannabis markets are seeing quicker starts to sales
As public opinion changes and state regulators learn from those who have gone before them, the time it takes from the approval of medical marijuana by voters or lawmakers to the first recreational sales in a market is getting shorter.
Study of Canadian Workers Shows No Link Between Cannabis Use And Workplace Injury
Workers in Canada who have toked up recently don’t appear to have faced any greater risk of a workplace injury than those who abstained, according to a new study out this week, suggesting that cannabis use isn’t necessarily linked to sloppiness on the job.
New Jersey Marijuana Sales Could Start Just Weeks After Election Day Under Key Senator’s Plan
If New Jersey voters approve a marijuana legalization referendum on their ballots next week, sales in the Garden State could get rolling at record speed.
Kansas Residents Support Legalizing Marijuana By A Large Margin, Poll Finds
A strong majority of Kansas residents support legalizing marijuana for adult use by a three-to-one margin, according to a new poll.
USDA Approves Indiana Hemp Plan
The US Department of Agriculture (USDA) on Thursday approved Indiana’s hemp plan – its third approved plan over the last week.
MPV announces CSE’s conditional approval of its transaction with Entheon Biomedical Corp.
Entheon Biomedical has received conditional approval from the CSE to commence public trading.
Huge Cost-Savings From Psychedelic Drug Therapy
MAPS' recent economic study revealed huge cost savings from MDMA-assisted therapy to treat PTSD. But that could be just the beginning of the savings.
Majority Of New Yorkers Support Marijuana Legalization, New Poll Shows As Governor Renews Reform Pledge
Support for legalizing marijuana in New York outpaces opposition by a margin of two to one, according to a new poll.
Marijuana legalization proponents outraising opponents 36-to-1 in 2020
Financial support for marijuana legalization, both medical and recreational, has grown significantly in 2020 compared to 2016.
MAPS Study: MDMA-Assisted Psychotherapy Will Be More Cost-Effective than Other Treatments for PTSD
MDMA-assisted psychotherapy for PTSD is estimated to produce cost savings of $103,200 per patient, over a 30-year treatment horizon.
European Union Will Raise THC Limits on Hemp
The European Parliament voted last week to raise industrial hemp THC limits from 0.2 percent to 0.3 percent, aligning them with most other programs including the U.S., Hemp Industry Daily reports.
New Jersey Lawmakers Approve Bill Providing Medical Marijuana Patient Insurance Benefits
Employment insurance benefits would be extended to cover the costs of medical marijuana for registered patients in New Jersey under a bill that cleared an Assembly committee on Monday